abstract |
Provided are materials and methods for treating epidemics of non-A non-B hepatitis virus (NANBV) infection. An anti-hepatitis C virus (HCV) antibody that immunologically binds to a site in a polypeptide consisting of a contiguous sequence of at least 8 amino acids, wherein the site is against HCV Providing an antibody that can be bound by an antibody and wherein the contiguous sequence of at least 8 amino acids is derived from an amino acid sequence having one or several deletions, insertions or substitutions in the amino acid sequence. [Selection figure] None |